Boosting Cognitive Function in Schizophrenia: The Impact of MIN-101 and Metformin
Versacloz® (clozapine, USP) Overview Versacloz is indicated for treatment-resistant schizophrenia in severely ill patients. Its use is restricted due to significant risks like agranulocytosis and seizures. The effectiveness of clozapine was established in a randomized study comparing it to chlorpromazine in patients who failed other antipsychotic treatments. Dosing for Versacloz involves a highly concentrated oral…